Here's hoping it's right...
"While John Hester says that
one of his to watch is Oncosil..
Code OSL.. (mkt cap $73m)
It reports interim results from a pivotal study in pancreatic cancer in a few days time
Chairman is Chris Roberts [ex Cochlear CEo and SRX Chair]
definitely one to watch.
Before all this Hester rated OSL 2nd to VLA after the SRX takeover.
12 Month rating was $0.41
- Forums
- ASX - By Stock
- OSL
- Bell Potter Coppo Report - big biotech piece...
OSL
oncosil medical ltd
Add to My Watchlist
2.03%
!
$1.45
Bell Potter Coppo Report - big biotech piece...
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
one of his to watch is Oncosil..